Glycolic Acid

Glycolic Acid

SCHEMBL162065

ClC[C@@H]1CNCCc2ccccc21.O=C(O)CO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.47
HTR2C P28335 4/20 0.47
HTR2A P28223 3/20 0.47
HTR2B P41595 3/20 0.47
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
DRD1 P21728 5/20 0.42
DRD2 P14416 4/20 0.42
OPRM1 P35372 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PRCP P42785 2/20 0.38
SLC22A1 O15245 1/20 0.38
MAPT P10636 3/20 0.37
DRD5 P21918 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
ADCY6 O43306 1/20 0.37
ADCY3 O60266 1/20 0.37
ADCY9 O60503 1/20 0.37
ADCY5 O95622 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL160930 0.92 TAAR1 (0.47) TAAR1HTR2CHTR2AHTR2BTSHR
Succinic Acid SCHEMBL161276 0.92 TAAR1 (0.47) TAAR1HTR2CHTR2AHTR2BTSHR
Adipic Acid SCHEMBL161399 0.90 HTR2C (0.48) TAAR1HTR2CHTR2AHTR2BTSHR
Adipic Acid SCHEMBL174687 0.90 HTR2C (0.48) TAAR1HTR2CHTR2AHTR2BTSHR
SCHEMBL163850 0.89 HTR2C (0.57) TAAR1HTR2CHTR2AHTR2BPRCP
SCHEMBL162669 0.89 HTR2C (0.57) TAAR1HTR2CHTR2AHTR2BPRCP
Fumaric Acid SCHEMBL159722 0.88 TAAR1 (0.46) TAAR1HTR2CHTR2AHTR2BTSHR
Maleic Acid SCHEMBL161822 0.88 TAAR1 (0.46) TAAR1HTR2CHTR2AHTR2BTSHR
Citric Acid SCHEMBL163928 0.88 TAAR1 (0.41) TAAR1HTR2CHTR2AHTR2BTSHR
Bromide SCHEMBL161200 0.87 HTR2C (0.56) TAAR1HTR2CHTR2AHTR2BPRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030953-A1 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed